Bridgebio Pharma Inc (BBIO)

12:32 PM

How buybacks impact BridgeBio Pharma Inc. stock valueJuly 2025 Trends & Daily Stock Trend Reports - Trung tâm Dự báo KTTV quốc gia

12:32 PM

12:21 PM

Why BridgeBio Pharma Inc. stock could be next big winnerQuarterly Investment Review & Low Risk Growth Stock Ideas - Trung tâm Dự báo KTTV quốc gia

12:21 PM

03:16 AM

BridgeBio Pharma Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com

03:16 AM

Oct 16, 2025

(BBIO) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Oct 16, 2025

Oct 16, 2025

Achondroplasia Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | BioMarin Pharmaceuticals, BridgeBio/ QED Therapeutics, Ribomic Inc, Sanofi - The Globe and Mail

Oct 16, 2025

Oct 15, 2025

BridgeBio Pharma Hits New 52-Week High of $57.47, Up 103% - Markets Mojo

Oct 15, 2025

Oct 15, 2025

Published on: 2025-10-15 10:59:59 - newser.com

Oct 15, 2025

Oct 15, 2025

Sentiment analysis tools applied to BridgeBio Pharma Inc.Trade Risk Assessment & Weekly High Conviction Ideas - newser.com

Oct 15, 2025

Oct 14, 2025

BridgeBio Pharma Hits New 52-Week High of $56.24, Up 101% Yearly - Markets Mojo

Oct 14, 2025

Oct 14, 2025

How big funds are accumulating BridgeBio Pharma Inc. (2CL) stockAnalyst Downgrade & Safe Capital Growth Plans - newser.com

Oct 14, 2025

Oct 14, 2025

BridgeBio Pharma stock hits 52-week high at 56.28 USD - Investing.com

Oct 14, 2025

Oct 14, 2025

Will BridgeBio Pharma Inc. bounce back from current support2025 Market Outlook & Expert Curated Trade Setups - newser.com

Oct 14, 2025

Oct 13, 2025

Long term hold vs stop loss in BridgeBio Pharma Inc.Trade Exit Summary & Verified Short-Term Plans - newser.com

Oct 13, 2025

Oct 13, 2025

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unlocking Potential with a 19.51% Upside and Revolutionary Biotech Ventures - DirectorsTalk Interviews

Oct 13, 2025

Oct 13, 2025

What indicators show strength in BridgeBio Pharma Inc.Index Update & Reliable Price Breakout Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

BridgeBio Pharma Hits New 52-Week High of $55.13, Up 94.83% - Markets Mojo

Oct 12, 2025

Oct 12, 2025

BridgeBio (BBIO) Leads Biotech Sector with Promising Pipeline - GuruFocus

Oct 12, 2025

Oct 12, 2025

SA Asks: What's the most attractive biotech stock right now? - Seeking Alpha

Oct 12, 2025

Oct 12, 2025

Oak Ridge Investments LLC Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Oct 12, 2025

Oct 12, 2025

Published on: 2025-10-12 03:32:49 - newser.com

Oct 12, 2025

Oct 11, 2025

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares - MarketBeat

Oct 11, 2025

Oct 10, 2025

BridgeBio Pharma CEO Kumar sells $4.38 million in BBIO stock - Investing.com

Oct 10, 2025

Oct 10, 2025

Using flow based indicators on BridgeBio Pharma Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

Why BridgeBio Pharma Inc. (2CL) stock could outperform next yearJuly 2025 Breakouts & AI Based Trade Execution Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

BridgeBio Pharma (NASDAQ:BBIO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

BridgeBio Pharma Hits New 52-Week High of $55.33, Up 98.71% - Markets Mojo

Oct 09, 2025

Oct 09, 2025

Using economic indicators to assess BridgeBio Pharma Inc. potentialJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Leading vs lagging indicators on BridgeBio Pharma Inc. performance2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Real time breakdown of BridgeBio Pharma Inc. stock performanceIPO Watch & Risk Managed Investment Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Will breakout in BridgeBio Pharma Inc. lead to full recoveryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025

Oct 08, 2025

BridgeBio Pharma, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 08, 2025

Oct 08, 2025

BridgeBio Pharma Hits New 52-Week High of $54.64, Up 96.23% - Markets Mojo

Oct 08, 2025

Oct 06, 2025

BridgeBio Pharma (NASDAQ:BBIO) Sets New 12-Month HighHere's What Happened - MarketBeat

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma stock hits 52-week high at $54.61 By Investing.com - Investing.com South Africa

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma stock hits 52-week high at $54.61 - Investing.com

Oct 06, 2025

Oct 06, 2025

Analyzing drawdowns of BridgeBio Pharma Inc. with statistical toolsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 06, 2025

Oct 06, 2025

PFG Investments LLC Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Oct 06, 2025

Oct 06, 2025

What MACD and RSI say about BridgeBio Pharma Inc.Weekly Market Outlook & Target Return Focused Stock Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Pattern recognition hints at BridgeBio Pharma Inc. upsideJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com

Oct 05, 2025

Oct 04, 2025

BridgeBio Pharma (BBIO) Is Up 5.6% After Acoramidis Shows Broad ATTR-CM Benefit in Phase 3 Data - Yahoo

Oct 04, 2025

Oct 04, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 04, 2025

Oct 03, 2025

BridgeBio Pharma reports inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

23,884 RSUs: BridgeBio Grants Inducement Shares with Quarterly Vesting Starting Nov. 16, 2026 - Stock Titan

Oct 03, 2025